EDMONTON, July 3 /CNW/ - CardioMetabolics(TM) Inc. (the “Company”), announced today that at its Annual and Special Meeting of Shareholders held on June 27, 2008, its shareholders approved a change in the Company’s name to Valens Pharma Ltd. All matters put before the shareholders at the meeting were approved including the reappointment of the Company’s Board of Directors, Dr. David Cox, Colin Eicher, Dr. Larry Ohlhauser, Yves Rosconi and Dr. Randall Yatscoff, Edward Taylor.
